Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state

Journal of Medical Microbiology

Volumn 48, Issue 8, 1999, Pages 731-740

  Santangelo, Rosemary T ^a,b   Nouri Sorkhabi, M Hossein ^a,c   Sorrell, Tania C ^a   Cagney, Michelle ^a   Chen, Sharon C A ^a   Kuchel, Philip W ^a,c   Wright, Lesley C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF WESTERN SYDNEY   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 BROMOPHENACYL BROMIDE; DITHIOTHREITOL; ENZYME INHIBITOR; LUNG SURFACTANT; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPASE; N BROMOSUCCINIMIDE; N ETHYLMALEIMIDE; PALMITOYLCARNITINE; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPASE; TRITON X 100;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; ENZYME SUBSTRATE; NEUTROPHIL; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RADIOMETRY;

CRYPTOCOCCUS NEOFORMANS;

EID: 0032858853     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-8-731     Document Type: Article

References (35)

1. 1. Dennis AE. Phospholipases. In: Boyer P (ed) The enzymes, 3rd ed, vol 16, Lipid enzymology. New York, Academic Press. 1983: 307-353.
2. 2. Weinstein J. Synovial fluid leukocytosis associated with intracellular lipid inclusions. Arch Intern Med 1980; 140: 560-561.
3. 2. J Appl Physiol 1989; 66: 261-267.
4. 4. Waite M. Phospholipases. In: Vance DE, Vance J (eds) Biochemistry of lipids, lipoproteins and membranes. Elsevier, Amsterdam. 1991: 269-295.
5. 5. Ibrahim AS, Mirbod F, Filler SG et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 1995; 63: 1993-1998.
6. 6. Birch M, Robson G, Law D, Denning DW. Evidence of multiple extracellular phospholipase activities of Aspergillus fumigatus. Infect Immun 1996; 64: 751-755.
7. 7. Kaneshiro ES. The lipids of Pneumocyatis carinii. Clin Microbiol Rev 1998; 11: 27-41.
8. 8. Chen SCA, Wright LC, Santangelo RT et al. Identification of extracellular phospholipase B, lysophospholipase and acyltransferase produced by Cryptococcus neoformans. Infect Immun 1997; 65: 405-411.
9. 9. Chen SCA, Muller M, Zhou JZ, Wright LC, Sorrell TC. Phospholipase activity in Cryptococcus neoformans: a new virulence factor? J Infect Dis 1997; 175: 414-420.
10. 10. Cherniak R, Sundstrom JB. Polysaccharide antigens of the capsule of Crytococcus neoformans. Infect Immun 1994; 62: 1507-1512.
11. 11. Kwon-Chung KJ, Polacheek I, Popkin TJ. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol 1982; 150: 1414-1421.
12. 12. Chaturvedi V, Wong B, Newman SL. Oxidative killing of Cryptococcus neoformans by human neulrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates. J Immunol 1996; 156: 3836-3840.
13. 13. Salyers AA, Whitt DD. Bacterial pathogenesis: a molecular approach. Washington, DC, ASM Press. 1994.
14. 14. Barrett-Bee K, Haynes Y, Wilson RG, Ryley JF. A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J Gen Microbiol 1985; 131: 1217-1221.
15. 15. Bligh EC, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
16. 16. Homer J, Roberts JK. The advantages of rapid multipulsing in the routine acquisition of NMR spectra. J Magn Reson 1989; 81: 484-490.
17. 17. Shaka AJ, Keeler J, Frenkiel T, Freeman R. An improved sequence for broadband decoupling: WALTZ-16. J Magn Reson 1983; 52: 335-338.
18. 18. May GL, Wright LC, Obbink KG et al. Increased saturated triacylglycerol levels in plasma membranes of human neutrophils stimulated by lipopolysaccharide. J Lipid Res 1997; 38: 1562-1570.
19. 19. Gross RW, Drisdel RC, Sobel BE. Rabbit myocardial lysophospholipase-transacylase. Purification, characterization, and inhibition by endogenous cardiac amphiphiles. J Biol Chem 1983; 258: 15165-15172.
20. 2. Br J Pharmacol 1986; 88: 463-472.
21. 21. Martin SJ, Reutelingsperger CPM, McGahon AJ et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initialing stimulus; inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182: 1545-1556.
22. 22. Takahashi M, Banno Y, Nozawa Y. Secreted Candida albicans phospholipase: purification and characterization of two forms of lysophospholipase-transacylase. J Med Vet Mycol 1991; 29: 193-204.
23. 23. Sugatani J, Okumura T, Saito K. Studies of a phospholipase B from Penicillium notatum: substrate specificity and properties of active site. Biochim Biophys Acta 1980; 620: 372-386.
24. 24. Saito K, Sugatani J, Okumura T. Phospholipase B from Penicillium notatum. Methods Enzymol 1991; 197: 446-456.
25. 25. Sugatani J, Kawasaki N, Saito K. Studies on phospholipase B from Pencillium notatum; substrate specificity. Biochim Biophys Acta 1978; 529: 29-37.
26. 26. Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant. FASEB J 1994; 8: 957-967.
27. 27. Mirbod F, Banno Y, Ghannoum MA et al. Purification and characterization of lysophospholipase-transacylase (h-LPTA) from a highly virulent strain of Candida albicans. Biochim Biophys Acta 1995; 1257: 181-188.
28. 28. Prakobphol A, Leffler H, Hoover CI, Fisher SJ. Palmitoyl carnitine, a lysophospholipase-transacylase inhibitor, prevents Candida adherence in vitro. FEMS Microbiol Lett 1997; 151: 89-94.
29. 29. Witt W, Schweingruber ME, Mertsching A, Phospholipase B from the plasma membrane of Saccharomyces cerevisiae: separation of two forms with different carbohydrate content. Biochim Biophys Acta 1984; 795: 108-116.
30. 30. Dong ZM, Murphy JW. Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of neutrophils. J Clin Invest 1996; 97: 689-698.
31. 31. Richardson MD, White LJ, McKay IC, Shankland GS. Differential binding of acapsulate and encapsulated strains of Cryptococcus neoformans to human neutrophils. J Med Vet Mycol 1993; 31: 189-199.
32. 32. Kamei K, Brummer E, Clemons KV, Stevens DA. Induction of stress protein synthesis in Histoplasma capsulatum by heat, low pH and hydrogen peroxide. J Med Vet Mycol 1992; 30: 385-393.
33. 33. Chander A, Johnson RG, Reicherter J, Fisher AB. Lung lamellar bodies maintain an acidic internal pH. J Biol Chem 1986; 261: 6126-6131.
34. 34. Diamond RH, Bennett JE. Growth of Cryptococcus neoformans with human macrophages. Infect Immun 1973; 7: 231-236.
35. 35. Vecchiarelli A, Dottorini M, Pietrella D et al. Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection. Am J Respir Cell Mol Biol 1994; 11: 130-137.